Submitted by Anonymous (not verified) on 2 October 2026 - 13:28
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised